Updates are available Correction dated 2019-01-11
Click to view Correction: https://0-doi-org.brum.beds.ac.uk/10.1186/s13059-019-1623-5
Updates are available Correction dated 2019-06-18
Click to view Correction: https://0-doi-org.brum.beds.ac.uk/10.1186/s13059-019-1737-9
-
Authors
Murat, Pierre
Marsico, Giovanni
Herdy, Barbara
Ghanbarian, Avazeh
Portella, Guillem
Balasubramanian, Shankar
-
Funding
Funding for this research was provided by:
Wellcome Trust (099232/z/12/z)
European Research Council (339778)
Cancer Research UK (C9681/A18618)
- License Information
-
More Information
Article History
Received: 16 March 2018
Accepted: 4 December 2018
First Online: 27 December 2018
Change Date: 18 June 2019
Change Type: Correction
Change Date: 11 January 2019
Change Type: Correction
Change Details: Following publication of the original article [1], the authors reported the following error in the name of the fourth author.
Change Details: Following publication of the original article [1], the authors reported the following error in the name of the fourth author.
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: SB is a founder and shareholder of Cambridge Epigenetrix Ltd. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
